Archives: Agenda

• Overview of Rare Diseases
• Designing Clinical Trials for Rare Diseases
• Overcoming Challenges in Rare Disease Trials
• Post-Trial Consideration

• Strengthening regulatory and ethical frameworks and ensuring trials follow global standards and Good Clinical Practice
• Building capacity and infrastructure, training researchers and enhancing facilities for high-quality trial execution
• Promoting data transparency and global collaboration, registering trials and sharing data to improve research outcomes
• Streamlining approval processes, speeding up trial initiation for urgent health needs while maintaining safety and compliance

Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Hosted by industry experts and each focused on a single issue, roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.

Roundtable session lasts for 30 minutes and rotate

ROUNDTABLE 1: What key aspects of inspection readiness should we be considering right now?

Sukyoung Kwon, Head of Clinical Operation, Taejoon Pharm

ROUNDTABLE 2: Getting the best out of your sponsor – CRO partnership

Dayeon Ko, Director of Clinical development, Enzychem Lifesciences

Join us for a chance to win one of our prizes, including Apple products